and while there are rumors that Apple is exploring foldable technology, there is no sign of a foldable iPhone coming in the immediate future. Apple's first foldable isn't expected to be an iPhone ...

He is a colorful raconteur who will guide you through the ever-changing, fast-paced world of phones, especially the iPhone and iOS ... reporting on Apple and the broader consumer tech industry.

which is also in line to get a larger display, upgraded camera and more current silicon. That latter move potentially allows the iPhone SE 4 to support the Apple Intelligence features that Apple ...

Sir Keir Starmer's Labour Party has a ruthless streak when it comes to suspending MPs who've brought the party into disrepute or failed to toe the line. It's no surprise that Andrew Gwynne was ...

A Face ID and Touch ID combination is possible for the "iPhone Fold." Apple uses A-series processors for its iPhone line, so the most obvious choice for the "iPhone Fold" would be the A17 Pro or ...

Hoda Kotb took her love for New Orleans on the road and attended the 2025 Super Bowl at Caesars Superdome. The former TODAY co-anchor captioned her carousel of pics, "Oh what funnnnn!!!" and added ...

Answer: A crash can occur anytime a driver chooses to cross over a solid or double solid yellow or white line. Engineers and safety personnel place these lane markers in areas where it’s unsafe ...

Eagles odds from SportsLine Consensus, while the over/under for total points scored is 48.5. The Chiefs are -123 money-line favorites (risk $123 to win $100) after opening at +130, while the ...

The line drew plenty of “oohs” and “ahhs” from the crowd, while the camera panned to Belichick and Hudson. She looked stunned while Belichick kept a straight narrow smile. Belichick ...

The Under Armour Next Football Camp series for 2025 gets underway in Atlanta this weekend. Here's a look at the loaded field of expected participants. Carrollton, Ga. — The rundown of prospects ...

Battle lines are being drawn up in metastatic castration-resistant prostate cancer (mCRPC), with AstraZeneca and Merck & Co’s market-leading PARP inhibitor Lynparza firmly in the sights of newer ...